Application of lercanidipine in the treatment of hypertension | Zendy

G. G Shehyan | Zendy; A. A Yalymov | Zendy; Zadionchenko Vs | Zendy; С И Варенцов | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Application of lercanidipine in the treatment of hypertension

Author(s) -

G. G Shehyan,

A. A Yalymov,

Zadionchenko Vs,

С И Варенцов

Publication year - 2014

Publication title -

cardiosomatics

Language(s) - English

Resource type - Journals

eISSN - 2658-5707

pISSN - 2221-7185

DOI - 10.26442/cs45099

Subject(s) - lercanidipine , tolerability , medicine , blood pressure , essential hypertension , heart rate , drug , antagonist , cardiology , adverse effect , pharmacology , receptor

The article presents data from clinical trials that have examined the efficacy and safety of modern calcium antagonist (CA) III generation of lercanidipine. The results of studies show that treatment with lercanidipine leads to a marked reduction in systolic and diastolic blood pressure without significant effect on heart rate. Unique pharmacokinetic characteristics of the drug provide its excellent efficacy and safety, good tolerability, convenience, acceptance and high adherence CA data in patients with hypertension. Additional properties of lercanidipine allow us to recommend the use of the CA in comorbidity.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research